Abstract
To date, the treatment of adult-onset Still’s disease (AOSD) has been largely empirical; therefore, this study was conducted to investigate the response to therapy and prognostic factors of AOSD. Fifty-four Korean patients with AOSD were enrolled based on Yamaguchi’s criteria. We retrospectively analyzed the treatments and prognosis. Thirty-nine patients (72.2%) were female, and the average age at disease onset was 37.3 years. Twenty-nine patients had a monocyclic disease (53.7%), five had a polycyclic (9.3%) and fifteen had a chronic articular disease (27.7%) and five died (9.3%). The elevated ESR and corticosteroids refractoriness were associated with poor prognosis (P = 0.023 and P = 0.009, respectively). The patients that died were older than those survived (49.2 ± 11.8 vs. 42.2 ± 14 year old, P = 0.024). Forty-two patients were treated with non-steroidal anti-inflammatory drugs; however, they also needed corticosteroids and intravenous immunoglobulin (IVIG). Among 50 patients treated with high-dose corticosteroids, 21 patients (42%) were resistant to corticosteroids and treated with IVIG or anti-tumor necrosis factor (TNF) agents. Of the 23 patients medicated with IVIG, the prognosis was better in IVIG-responsive patients, indicating a therapeutic effect. Methotrexate was the most commonly used disease modifying anti-rheumatic drugs (27 patients, 50%), and the corticosteroid requirements were lower in the methotrexate-responsive patients. Approximately half of AOSD patients had a poor prognosis and were corticosteroids resistance. An elevated ESR and non-response to corticosteroids were associated with poor prognosis. Patients who died were older than those survived.
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00296-011-1801-6/MediaObjects/296_2011_1801_Fig1_HTML.gif)
Similar content being viewed by others
References
Bywaters EG (1971) Still’s disease in the adult. Ann Rheum Dis 30:121–133
Fautrel B (2008) Adult-onset Still disease. Best Pract Res Clin Rheumatol 22:773–792
Ohta A, Yamaguchi M, Kaneoka H et al (1987) Adult Still’s disease: review of 228 cases from the literature. J Rheumatol 14:1139–1146
Pouchot J, Sampalis JS, Beaudet F et al (1991) Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118–136
Cagatay Y, Gul A, Cagatay A et al (2009) Adult-onset Still’s disease. Int J Clin Pract 63:1050–1055
Efthimiou P, Kontzias A, Ward CM et al (2007) Adult-onset Still’s disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol 3:328–335
Magadur-Joly G, Billaud E, Barrier JH et al (1995) Epidemiology of adult Still’s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 54:587–590
Wakai K, Ohta A, Tamakoshi A et al (1997) Estimated prevalence and incidence of adult Still’s disease: findings by a nationwide epidemiological survey in Japan. J Epidemiol 7:221–225
Coffernils M, Soupart A, Pradier O et al (1992) Hyperferritinemia in adult onset Still’s disease and the hemophagocytic syndrome. J Rheumatol 19:1425–1427
Reginato AJ, Schumacher HR Jr, Baker DG et al (1987) Adult onset Still’s disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 17:39–57
Hirohata S, Kamoshita H, Taketani T et al (1986) Adult Still’s disease complicated with adult respiratory distress. Arch Intern Med 146:2409–2410
Akritidis N, Sakkas LI (1995) Adult onset Still’s disease. 16 cases. Presse Med 24:1207–1208
Andres E, Kurtz JE, Perrin AE et al (2003) Retrospective monocentric study of 17 patients with adult Still’s disease, with special focus on liver abnormalities. Hepatogastroenterology 50:192–195
Evensen KJ, Nossent HC (2006) Epidemiology and outcome of adult-onset Still’s disease in Northern Norway. Scand J Rheumatol 35:48–51
Chen DY, Lan JL, Hsieh TY et al (2004) Clinical manifestations, disease course, and complications of adult-onset Still’s disease in Taiwan. J Formos Med Assoc 103:844–852
Ohta A, Yamaguchi M, Tsunematsu T et al (1990) Adult Still’s disease: a multicenter survey of Japanese patients. J Rheumatol 17:1058–1063
Uppal SS, Pande IR, Kumar A et al (1995) Adult onset Still’s disease in northern India: comparison with juvenile onset Still’s disease. Br J Rheumatol 34:429–434
Cush JJ, Medsger TA Jr, Christy WC et al (1987) Adult-onset Still’s disease. Clinical course and outcome. Arthritis Rheum 30:186–194
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Pay S, Turkcapar N, Kalyoncu M et al (2006) A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 25:639–644
Zeng T, Zou YQ, Wu MF et al (2009) Clinical features and prognosis of adult-onset still’s disease: 61 cases from China. J Rheumatol 36:1026–1031
Fitzgerald AA, Leclercq SA, Yan A et al (2005) Rapid responses to anakinra in patients with refractory adult-onset Still’s disease. Arthritis Rheum 52:1794–1803
Fautrel B, Sibilia J, Mariette X et al (2005) Tumour necrosis factor alpha blocking agents in refractory adult Still’s disease: an observational study of 20 cases. Ann Rheum Dis 64:262–266
Kokkinos A, Iliopoulos A, Greka P et al (2004) Successful treatment of refractory adult-onset Still’s disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 23:45–49
Benucci M, Li GF, Del Rosso A et al (2005) Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still’s disease: the first case report. Clin Exp Rheumatol 23:733
Efthimiou P, Georgy S (2006) Pathogenesis and management of adult-onset Still’s disease. Semin Arthritis Rheum 36:144–152
Maier J, Birkenfeld G, Pfirstinger J et al (2008) Effective treatment of steroid refractory adult-onset Still’s disease with anakinra. J Rheumatol 35:939–941
Lequerre T, Quartier P, Rosellini D et al (2008) Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 67:302–308
Naumann L, Feist E, Natusch A et al (2010) IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still’s disease. Ann Rheum Dis 69:466–467
Kotter I, Wacker A, Koch S et al (2007) Anakinra in patients with treatment-resistant adult-onset Still’s disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum 37:189–197
Mahmud T, Hughes GR (1999) Intravenous immunoglobulin in the treatment of refractory adult Still’s disease. J Rheumatol 26:2067–2068
Permal S, Wechsler B, Cabane J et al (1995) Treatment of Still disease in adults with intravenous immunoglobulins. Rev Med Interne 16:250–254
Vignes S, Wechsler B, Amoura Z et al (1998) Intravenous immunoglobulin in adult Still’s disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol 16:295–298
Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult onset Still’s disease. Ann Rheum Dis 65:564–572
Kraetsch HG, Antoni C, Kalden JR et al (2001) Successful treatment of a small cohort of patients with adult onset of Still’s disease with infliximab: first experiences. Ann Rheum Dis 60:55–57
Husni ME, Maier AL, Mease PJ et al (2002) Etanercept in the treatment of adult patients with Still’s disease. Arthritis Rheum 46:1171–1176
Fautrel B, Borget C, Rozenberg S et al (1999) Corticosteroid sparing effect of low dose methotrexate treatment in adult Still’s disease. J Rheumatol 26:373–378
Fujii T, Akizuki M, Kameda H et al (1997) Methotrexate treatment in patients with adult onset Still’s disease–retrospective study of 13 Japanese cases. Ann Rheum Dis 56:144–148
Kontzias A, Efthimiou P (2008) Adult-onset Still’s disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs 68:319–337
Acknowledgments
This study was supported by the Brain Korea 21 project for Ajou University School of Medicine, Ministry of Health & Welfare, R.O.K. (A050571).
Conflict of interest
We have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, HA., Sung, JM. & Suh, CH. Therapeutic responses and prognosis in adult-onset Still’s disease. Rheumatol Int 32, 1291–1298 (2012). https://doi.org/10.1007/s00296-011-1801-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-1801-6